Literature DB >> 30638413

Morphology and Composition of the Inner Limiting Membrane: Species-Specific Variations and Relevance toward Drug Delivery Research.

Karen Peynshaert1,2, Joke Devoldere1,2, An-Katrien Minnaert1,2, Stefaan C De Smedt1,2, Katrien Remaut1,2.   

Abstract

The inner limiting membrane (ILM) represents the structural boundary between the vitreous and the retina, and is suggested to act as a barrier for a wide range of retinal therapies. While it is widely acknowledged that the morphology of the human ILM exhibits regional variations and undergoes age-related changes, insight into its structure in laboratory animals is very limited. Besides presenting a detailed overview of the morphology and composition of the human ILM, this review specifically reflects on the species-specific differences in ILM structure. With these differences in mind, we furthermore summarize the most relevant reports on the barrier role of the ILM with regard to viral vectors, nanoparticles, anti-VEGF medication and stem cells. Overall, this review aims to deliberate on the impact of species-specific ILM variations on drug delivery research as well as to pinpoint knowledge gaps which future basic research should resolve.

Entities:  

Keywords:  Inner limiting membrane; nanoparticles; species variations; viral vector; vitreoretinal interface

Mesh:

Substances:

Year:  2019        PMID: 30638413     DOI: 10.1080/02713683.2019.1565890

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  Fundus imaging of retinal ganglion cells transduced by retrograde transport of rAAV2-retro.

Authors:  Rakesh Nanjappa; Mikayla D Dilbeck; John R Economides; Jonathan C Horton
Journal:  Exp Eye Res       Date:  2022-04-20       Impact factor: 3.770

Review 2.  Nanoparticles for the treatment of glaucoma-associated neuroinflammation.

Authors:  Lidawani Lambuk; Nurfatihah Azlyna Ahmad Suhaimi; Muhammad Zulfiqah Sadikan; Azliana Jusnida Ahmad Jafri; Suhana Ahmad; Nurul Alimah Abdul Nasir; Vuk Uskoković; Ramlah Kadir; Rohimah Mohamud
Journal:  Eye Vis (Lond)       Date:  2022-07-02

Review 3.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

Review 4.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

Review 5.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24

Review 6.  Immune responses to injury and their links to eye disease.

Authors:  Mary Ann Stepp; A Sue Menko
Journal:  Transl Res       Date:  2021-05-27       Impact factor: 10.171

7.  The MDM2 Single-Nucleotide Polymorphism T309G Is Associated With the Development of Epimacular Membranes.

Authors:  Heng Jiang; Bin Yan; Zhishang Meng; Lusi Zhang; Hetian Lei; Jing Luo
Journal:  Front Cell Dev Biol       Date:  2022-03-14

8.  Photodisruption of the Inner Limiting Membrane: Exploring ICG Loaded Nanoparticles as Photosensitizers.

Authors:  Kaat De Clerck; Geraldine Accou; Félix Sauvage; Kevin Braeckmans; Stefaan C De Smedt; Katrien Remaut; Karen Peynshaert
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

9.  Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells.

Authors:  Kevin Y Zhang; Caitlyn Tuffy; Joseph L Mertz; Sarah Quillen; Laurence Wechsler; Harry A Quigley; Donald J Zack; Thomas V Johnson
Journal:  Stem Cell Reports       Date:  2020-12-30       Impact factor: 7.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.